Journal
EXPERIMENTAL CELL RESEARCH
Volume 349, Issue 1, Pages 15-22Publisher
ELSEVIER INC
DOI: 10.1016/j.yexcr.2016.08.012
Keywords
Vitamin D receptor (VDR); Crosstalk; Transrepression; MiR-214; Breast cancer; Hedgehog signaling
Categories
Funding
- UNCF/MERCK Postdoctoral Science Research Fellowship
- National Institutes of Health (NIH) [R01-140321]
Ask authors/readers for more resources
The vitamin D receptor (VDR), and its ligand la,25-dihydroxyvitamin D-3 (1,25D(3)) prevent breast cancer development and progression, yet the molecular mechanisms governing this are unclear. MicroRNAs (miRNAs) on the other hand, promote or inhibit breast cancer growth. To understand how VDR regulates miRNAs, we compared miRNA expression of wild-type (WT) and VDR knockout (VDRKO) breast cancer cells by a Mouse Breast Cancer miRNA PCR array. Compared to VDR WT cells, expressions of miR-214, miR-199a-3p and miR199a-5p of the miR-199a/miR-214 cluster were 42, 15, and 10 fold higher in VDRKO cells respectively. Overexpression of VDR in breast cancer cells reduced the miR-199a/miR-214 cluster expression by 30%. VDR status also negatively correlated with Dnm3os expression, a non-coding RNA transcript of the dynamin-3 gene encoding the miR-199a/miR-214 cluster, suggesting that VDR represses this cluster through Dnm3os. Conversely, overexpression of miR-214 in MCF-7 and T47D cells antagonized VDR mediated signaling. Furthermore, there was a positive correlation between VDR status and the expression of Suppressor of fused gene (SuFu), a hedgehog pathway inhibitor. miR-214 on the other hand suppressed SuFu protein expression. These findings suggest a crosstalk between VDR and miR-214 in regulating hedgehog signaling in breast cancer cells, providing new therapies for breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available